Diagnosis

Liver abscess

A collection of pus in the liver.

Etiology

Cause [moc]

Pathophysiology [moc]

Risk factors [moc]

Complications [moc]

Epidemiology

Incidence per 100.000 [moc][kpn][cbb][gmk][wmq][qg9][bbn][hte][fv6]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Chills, Cough, Dark urine, Dyspnea, Fever, Hepatomegaly, Hypotension, Icterus, Malaise, Nausea, Night sweats, Tachycardia, Tachypnea, Vomiting, Weight loss

Clinical findings

Cholestasis, Elevated ALAT, Elevated ALP, Elevated ASAT, Elevated CRP, Elevated GGT, Jaundice, Leukocytosis

Anamneses

None listed.

Localized findings

Pain
Radiates
RUQ (Right Upper Quadrant)
Onset
Gradual (days)
Pattern
Constant
Severity
Mild (1-3)Moderate (4-7)

Approach

Treatment

  1. Drainage: Ubi pus, ibi evacua (Where there is pus, evacuate it) [moc]

    • Needle aspiration (sometimes repeated) might be sufficient for abscesses <5 cm

    • US or CT-guided if possible

    • Laparoscopic

    • Open surgery: peritonitis, thick wall abscesses, ruptured abscess, multiple large abscesses, and previously failed drainage procedures

  2. Antibiotic treatment: intravenous and then oral for total duration of two to six weeks

    • Cephalosporins + Metronidazole

    • Penicillins + Aminoglycosides + Metronidazole

    • Carbapenems in case of allergy

    • Culture results help narrow down the organism, so empiric treatment is no longer needed, as it can lead to antibiotic resistance

    • Echinococcus --> benzimidazole (albendazole) for several years

Differential diagnoses

Anaphylaxis, Appendicitis, Autoimmune hepatitis, Budd-Chiari syndrome, Cholangitis, Cholecystitis, Choledocholithiasis, Cholelithiasis, Drug-induced liver injury, Endocarditis, Gastritis, Hepatocellular carcinoma, Pneumonia, Sepsis, Shock, Viral hepatitis


References

[1] Akhondi H, Sabih DE. Liver Abscess. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538230/

[2] Zimmermann L, Wendt S, Lübbert C, Karlas T. Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance. United European Gastroenterol J. 2021 Nov;9(9):1039-1047.

[3] Tsai FC, Huang YT, Chang LY, Wang JT. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis. 2008 Oct;14(10):1592-600.

[4] Chen YC, Lin CH, Chang SN, Shi ZY. Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the National Health Insurance Research Database of Taiwan, 2000-2011. J Microbiol Immunol Infect. 2016 Oct;49(5):646-653.

[5] Yeh PJ, Chen CC, Lai MW, Yeh HY, Chao HC. Pediatric Liver Abscess: Trends in the Incidence, Etiology, and Outcomes Based on 20-Years of Experience at a Tertiary Center. Front Pediatr. 2020 Mar 24;8:111.

[6] Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004 Nov;2(11):1032-8.

[7] Sharma A, Mukewar S, Mara KC, Dierkhising RA, Kamath PS, Cummins N. Epidemiologic Factors, Clinical Presentation, Causes, and Outcomes of Liver Abscess: A 35-Year Olmsted County Study. Mayo Clin Proc Innov Qual Outcomes. 2018 Feb 22;2(1):16-25.

[8] Svensson, E., Jönsson, A., Bläckberg, A., Sunnerhagen, T., Kiasat, A., & Ljungquist, O. (2023). Increasing incidence of pyogenic liver abscess in Southern Sweden: a population-based study from 2011 to 2020. Infectious Diseases, 55(6), 375–383.

[9] Losie, J.A., Lam, J.C., Gregson, D.B. et al. Epidemiology and risk factors for pyogenic liver abscess in the Calgary Health Zone revisited: a population-based study. BMC Infect Dis 21, 939 (2021).

Scroll to top